4//SEC Filing
INNOVUS PHARMACEUTICALS, INC. 4
Accession 0001415889-15-001202
CIK 0001411879operating
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 6:19 AM ET
Size
5.9 KB
Accession
0001415889-15-001202
Insider Transaction Report
Form 4
Damaj Bassam
DirectorPresident and CEO10% Owner
Transactions
- Award
Restricted Stock Unit
2015-03-31+4,500,000→ 4,500,000 total→ Common Stock (4,500,000 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
- [F2]The Reporting Person was granted a Restricted Stock Unit award on March 31, 2015 of 4,500,000 shares, of which 1,500,000 vested immediately and the remaining 3,000,000 shares will vest in equal installments on a monthly basis over the next twenty-four (24) months.
- [F3]These restricted stock units are scheduled to vest 100% on March 31, 2017.
- [F4]These restricted stock units were granted pursuant to the Issuer's 2014 Equity Incentive Plan.
Documents
Issuer
INNOVUS PHARMACEUTICALS, INC.
CIK 0001411879
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001411879
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 6:19 AM ET
- Size
- 5.9 KB